MOORE MEDICAL BISMUTH- bismuth subsalicylate tablet, chewable 
Moore Medical LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Moore Medical Bismuth

Drug Facts

Active ingredient (in each tablet)

Bismuth Subsalicylate 262mg

(each tablet contains 102 mg salicylate)

Purpose

Upset stomach reliever/antidiarrheal

Uses

Temporarily relieves

■ traveler’s diarrhea

■ diarrhea

■ upset stomach due to overindulgence in food and drink, including:

■ heartburn ■ indigestion ■ nausea ■ gas ■ belching ■ fullness

Warnings

Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's Syndrome a rare but serious illness.

Allergy alert: Contains salicylate. Do not take if you are:

  • allergic to salicylates (including aspirin)
  • taking other salicylate products

Do not use if you have

  • bloody or black stool
  • an ulcer
  • a bleeding problem

Ask a doctor before use if you have

  • fever
  • mucus in the stool

Ask a doctor or pharmacist if you are taking any drug for

  • anticoagulation (thinning of the blood)
  • diabetes
  • gout
  • arthritis

Stop use and ask a doctor if

  • symptoms get worse
  • ringing in the ears or loss of hearing occurs
  • diarrhea lasts more than 2 days

When using this product

a temporary and harmless darkening of the tongue and/or stool may occur. Stool darkening should not be confused with melena.

If pregnant or breast-feeding,

ask a health professional before use.

Keep this and all drugs out of reach of children.

In case of accidental overdose, contact a physician or poison control center immediately.

Directions

Adults and children: (12 years and older) Take 2 tablets every 1/2 to 1 hour or 4 tablets every hour as needed

Children under 12 years: Do not give to children under 12 years of age.

Other information

Inactive ingredients

acacia gum, aspartame, calcium carbonate, D&C red #27, dextrates, flavoring, magnesium stearate, maltodextrin, microcrystalline cellulose, silicon dioxide

Questions or comments?

Call 800.234.1464

Moore Medical Bismuth Label

moore medical

Supporting Health and Care

Reorder No. 82473

UPN# 0-0607415-82473-5

Moore Brand®

Bismuth Tablets

100 Packets/2 Tablets

Controls diarrhea within 24 hours,
relieving associated abdominal cramps;
provides soothing relief for:
indigestion, upset stomach, heartburn and nausea.

Bismuth Subsalicylate 262 mg

Chew or crush tablets completely before swallowing.

Do not swallow tablets whole.

To Reorder:

Call: 800.234.1464

Fax: 800.944.6667

Online: www.mooremedical.com

Moore

MOORE MEDICAL BISMUTH 
bismuth subsalicylate tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:55670-474
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (SALICYLIC ACID - UNII:O414PZ4LPZ, BISMUTH CATION - UNII:ZS9CD1I8YE) BISMUTH SUBSALICYLATE262 mg
Inactive Ingredients
Ingredient NameStrength
ACACIA (UNII: 5C5403N26O)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
ASPARTAME (UNII: Z0H242BBR1)  
CALCIUM CARBONATE (UNII: H0G9379FGK)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
DEXTRATES (UNII: G263MI44RU)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Product Characteristics
ColorpinkScoreno score
ShapeROUNDSize16mm
FlavorImprint Code RH;046
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:55670-474-47100 in 1 BOX04/01/201407/31/2024
12 in 1 PACKET; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart33504/01/201407/31/2024
Labeler - Moore Medical LLC (051420107)

Revised: 3/2022
Document Id: da57b311-87e7-4b20-e053-2a95a90a632c
Set id: 0666d58a-2805-06e5-e054-00144ff88e88
Version: 10
Effective Time: 20220316
 
Moore Medical LLC